AXA Framlington Biotech Fund - R AccumulationRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 8.60 | -7.33 | 18.11 | 31.43 | 2.38 | 2.89 | 1.05 | 6.75 |
+/- Category | -1.69 | 0.63 | -2.09 | 5.46 | 11.42 | 10.73 | 2.33 | 7.30 |
+/- Category Index | -6.59 | -5.48 | 1.40 | -1.51 | 2.09 | 0.43 | -6.28 | -11.11 |
% Rank in Category | 66 | 56 | 62 | 20 | 16 | 27 | 32 | 19 |
Trailing Returns (GBP) | 15/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.60 | -1.27 | 0.88 |
1 Week | 5.18 | -0.86 | 4.20 |
1 Month | 5.56 | 1.68 | 3.67 |
3 Months | 10.70 | 9.65 | -0.86 |
6 Months | 9.06 | 7.26 | -7.09 |
YTD | 10.58 | 8.47 | -7.35 |
1 Year | 20.38 | 9.87 | -15.98 |
3 Years Annualised | 6.13 | 10.15 | -2.41 |
5 Years Annualised | 9.72 | 2.39 | -3.16 |
10 Years Annualised | 9.88 | 0.06 | -2.17 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.36 | 2.29 | - | - |
2023 | -4.17 | -1.26 | 0.00 | 6.80 |
2022 | -8.91 | -0.35 | 15.65 | -1.99 |
2021 | -6.49 | 7.82 | 5.09 | -3.37 |
2020 | 0.11 | 28.96 | -2.55 | 4.46 |
2019 | 15.82 | -0.22 | -9.27 | 12.65 |
|
Advertisement |